Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website
деньги взаймы онлайн на карту

NICU

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

  • by MNK Communications
  • Posted on September 30, 2020February 23, 2021
  • Advocacy

As we close out the month of September, which is Neonatal Intensive Care Unit (NICU) Awareness Month, we reflect on what it means for both parents and healthcare providers to experience a NICU stay. To […]

Read More

Mallinckrodt Supports Hand to Hold’s First Podcast for Parents of Preemies

  • by Gena Holthaus
  • Posted on February 22, 2017February 27, 2017
  • Advocacy

Support from Mallinckrodt Pharmaceuticals is helping make possible NICU Now, a free audio support series for parents of premature babies that covers such topics as guilt, grief, anxiety, bonding with a sick or medically fragile […]

Read More

Mallinckrodt Announces New Global Corporate Headquarters in UK

  • by Gena Holthaus
  • Posted on December 19, 2016February 27, 2017
  • Achievements

Mallinckrodt has announced plans to establish its new Global Corporate Headquarters in Staines-upon-Thames, outside of London. The announcement was made during a luncheon attended by Mallinckrodt employees, along with city and county council members, representatives […]

Read More
  • A Message from Mallinckrodt CEO Mark Trudeau Regarding Asian American Attacks

    March 18, 2021
  • Let’s Address Racial Inequities in Healthcare by Living Our Shared Company Values

    February 23, 2021
  • NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

    September 30, 2020
  • Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

    August 19, 2020
  • MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

    June 30, 2020

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

A Message from Mallinckrodt CEO Mark Trudeau Regarding Asian American Attacks

Let’s Address Racial Inequities in Healthcare by Living Our Shared Company Values

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.